Date Title Description PDF
24 Jul 2025 On P&L The Company releases the press release related to the first half of 2025 financial results Download
24 Jul 2025 On P&L The Company releases the first half 2025 financial results presentation Download
25 Mar 2025 On business and financial situation The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day Download
25 Feb 2025 On P&L The Company releases the press release related to the full year 2024 financial results Download
25 Feb 2025 On P&L The Company releases the full year 2024 financial results presentation Download

Pages

15 / 63
Date Title Description PDF
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download
07 Oct 2021 Liquidity and counterparty agreements Download
04 Oct 2021 Liquidity and counterparty agreements Download
01 Sep 2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine Download

Pages

140 / 175
Date Title Description PDF
08 May 2019 Information on P&L ROVI releases the first quarter 2019 results presentation Download
08 May 2019 Information on P&L ROVI releases the press release related to the first quarter 2019 financial results Download
07 May 2019 Liquidity contracts and specialists ROVI announces the signature of a new liquidity contract with Renta 4 Banco, S.A.     Download
30 Apr 2019 Liquidity contracts and specialists ROVI announces the termination of the liquidity contract signed with JB Capital Markets, S.V., S.A.U.     Download
11 Apr 2019 Strategic agreements with third parties The Company releases the press release related to the marketing agreement of Tetridar® in Spain   Download

Pages

20 / 194